UK Markets closed

Onxeo SA (0NWK.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.5825+0.5825 (+75.09%)
At close: 5:43PM BST
Full screen
Previous close0.7305
Open0.5825
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.5825 - 0.5825
52-week range0.5825 - 0.5825
Volume2,370
Avg. volumeN/A
Market cap32.914M
Beta (5Y monthly)1.49
PE ratio (TTM)58.25
EPS (TTM)0.0100
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Onxeo Reports Its 2021 Half-Yearly Financial Results and Provides an Update on Its Activities

    PARIS, July 29, 2021--Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North: ONXEO), « Onxeo », a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR) in oncology, today announced its consolidated half-yearly financial results to June 30, 2021 and provides an update on its activities.

  • Globe Newswire

    Onxeo Announces the Appointment of Dr. Shefali Agarwal as the Company’s Chairwoman of the Board

    Danièle Guyot-Caparros, outgoing Chairwoman, remains an independent member of the Board of Directors and Chair of the Audit Committee Paris (France), July 29, 2021 (GLOBE NEWSWIRE) -- Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North: ONXEO), « Onxeo », a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR) in oncology, today announced the appointment of Dr Shefali Agarwal as the Company’s Chairwoman of the

  • Business Wire

    Summary of Onxeo’s Liquidity Contract with Kepler Cheuvreux

    PARIS, July 13, 2021--Regulatory News: Pursuant to the liquidity contract granted to Kepler Cheuvreux regarding Onxeo (Paris:ALONX) (NASDAQ OMX:ALONX) shares, the following resources were listed in the liquidity account as at June 30, 2021, settlement date: